Performance of Wearers of Stenfilcon A Contact Lenses After A Refit With Test Lenses
- Conditions
- Myopia
- Interventions
- Device: Test lensDevice: control lens
- Registration Number
- NCT03496701
- Lead Sponsor
- Coopervision, Inc.
- Brief Summary
The aim of this study is to determine if habitual or adapted wearers of stenfilcon A control contact lenses can be refit into test lenses and be successful after one week of daily wear.
- Detailed Description
This study is a prospective, multi-center, open label, bilateral, daily wear, one week dispensing study comparing performance of wearers of stenfilcon A control contact lenses after refit with test contact lenses.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 77
A person is eligible for inclusion in the study if he/she:
- Is between 18 and 35 years of age (inclusive)
- Has read and signed the informed consent letter
- Is willing and anticipated to follow instructions and maintain the appointment schedule
- Habitually wears soft spherical contact lenses with a power between -1.00D to -6.00D (inclusive) for a minimum 5 days per week, 10 hours per day and anticipates no difficulty wearing contact lenses for 7 days per week, 10 hours per day.
- Habitually wears or is able to be adequately refit into MyDay Sphere lenses
- Demonstrates an acceptable fit with the study lenses
- Is correctable to a distance visual acuity of 0.20 logMAR (approximately 20/30) or better (in each eye) with the study contact lenses
- Uses digital devices, (e.g. computer, tablet, smart phone, iPad), for more than 4 hours a day, 5 days a week.
- Manifest cylindrical spectacle refraction does not exceed -0.75DC in either eye
- Has clear corneas and no active ocular disease
- Has a contact lens refraction that fits within the available parameters of the study lenses.
A person will be excluded from the study if he/she:
-
Is participating in any concurrent clinical research study
-
Has a history of not achieving comfortable CL wear (5 days per week; > 8 hours/day)
-
Has a systemic condition that, in the opinion of the investigator, may affect the study measures
-
Is using any systemic or topical medications that in the opinion of the investigator may affect the study measures.
-
Presents with slit lamp findings or clinically significant anterior segment abnormalities that would contraindicate contact lens wear such as:
- Pathological dry eye or associated findings
- Significant pterygium, pinguecula, or corneal scars within the visual axis
- Neovascularization > 0.75 mm in from of the limbus
- Giant papillary conjunctivitis (GCP) worse than grade 1
- Anterior uveitis or iritis (or history in past year)
- Seborrheic eczema of eyelid region, Seborrheic conjunctivitis
- History of corneal ulcers or fungal infections
- Poor personal hygiene
-
Has a known history of corneal hypoesthesia (reduced corneal sensitivity)
-
Has a known sensitivity to the diagnostic pharmaceuticals to be used in the study
-
Has aphakia, keratoconus or a highly irregular cornea.
-
Has presbyopia or has dependence on spectacles for near work over the contact lenses.
-
Has undergone refractive surgery.
-
Is pregnant, lactating or planning a pregnancy (by verbal communication) at the time of enrollment
-
Has participated in any other type of eye related clinical or research study within the last 7 days
-
Is habitually using rewetting/ lubricating eye drops (more than once per day)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Stenfilcon A / Test lens control lens All subjects will first wear stenfilcon A contact lenses for one week, then refitted with test contact lenses to wear for one week. Stenfilcon A / Test lens Test lens All subjects will first wear stenfilcon A contact lenses for one week, then refitted with test contact lenses to wear for one week.
- Primary Outcome Measures
Name Time Method Overall Lens Fit Acceptance 1 week on each study lenses Overall lens fit acceptance on a scale of 0-4, 0.5 steps (Scale: 0=should not be worn, 4=perfect)
- Secondary Outcome Measures
Name Time Method Lens Centration 1 week on each study lenses Lens centration was assessed on a 3 point scale (1-Optimum, 2- Decentration acceptable, 3-Decentration unacceptable)
Post-blink Movement 1 week on each study lenses Post-blink movement assessed on a scale of 0-4, 1 step size (Scale: 0=Insufficient, 1=Minimal, 2=Optimal, 3=Moderate, 4=Excessive)
Trial Locations
- Locations (4)
Nittany Eye Associates
🇺🇸State College, Pennsylvania, United States
Golden Optometric Group
🇺🇸Whittier, California, United States
Eric White, O.D., Inc.
🇺🇸San Diego, California, United States
Golden Vision
🇺🇸Sarasota, Florida, United States